NZ541254A - Conjugates obtained by reductive amination of serotype 5 pneumococcus capsular polysaccharide - Google Patents
Conjugates obtained by reductive amination of serotype 5 pneumococcus capsular polysaccharideInfo
- Publication number
- NZ541254A NZ541254A NZ541254A NZ54125404A NZ541254A NZ 541254 A NZ541254 A NZ 541254A NZ 541254 A NZ541254 A NZ 541254A NZ 54125404 A NZ54125404 A NZ 54125404A NZ 541254 A NZ541254 A NZ 541254A
- Authority
- NZ
- New Zealand
- Prior art keywords
- polysaccharide
- formula
- reductive amination
- conjugate
- aminated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0300488A FR2850106B1 (fr) | 2003-01-17 | 2003-01-17 | Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5 |
| PCT/FR2004/000089 WO2004067574A1 (fr) | 2003-01-17 | 2004-01-16 | Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ541254A true NZ541254A (en) | 2008-07-31 |
Family
ID=32605815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ541254A NZ541254A (en) | 2003-01-17 | 2004-01-16 | Conjugates obtained by reductive amination of serotype 5 pneumococcus capsular polysaccharide |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7812006B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1590373B1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101044437B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE520718T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004207647B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0406819B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2512847C (cg-RX-API-DMAC7.html) |
| DK (1) | DK1590373T3 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2850106B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL169689A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05007533A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ541254A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004067574A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2000278267A1 (en) | 2000-09-01 | 2002-03-22 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Vibrio cholerae o139 conjugate vaccines |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| IL308456A (en) | 2005-04-08 | 2024-01-01 | Wyeth Llc | A multivalent pneumomuroral protein-polysaccharide conjugate preparation |
| US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US8808707B1 (en) | 2006-05-08 | 2014-08-19 | Wyeth Llc | Pneumococcal dosing regimen |
| US9522382B2 (en) * | 2011-09-06 | 2016-12-20 | Biologistics Llc | Affinity/lectin chromatography methods |
| EP2755683B1 (en) * | 2011-09-14 | 2019-04-03 | GlaxoSmithKline Biologicals SA | Methods for making saccharide-protein glycoconjugates |
| US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| EP3303357B1 (en) | 2015-06-08 | 2021-05-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Vaccines against streptococcus pneumoniae serotype 5 |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| IL267709B2 (en) | 2016-12-30 | 2025-04-01 | Vaxcyte Inc | Polypeptide-antigen conjugates with unnatural amino acids |
| US20200061542A1 (en) * | 2017-02-24 | 2020-02-27 | Merck Sharp & Dohme Corp. | Methods for improving filterability of polysaccharide-protein conjugate reactions |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| EP3720483B1 (en) | 2017-12-06 | 2025-11-19 | Merck Sharp & Dohme LLC | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| EP3897705A2 (en) | 2018-12-19 | 2021-10-27 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| US20230405137A1 (en) * | 2020-11-10 | 2023-12-21 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| CN120607643B (zh) * | 2025-07-24 | 2026-05-12 | 江苏中慧元通生物科技股份有限公司 | 一种肺炎球菌单价多糖的纯化工艺 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902506A (en) * | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
| US4761283A (en) * | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
| US5153312A (en) * | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| FR2682388B1 (fr) | 1991-10-10 | 1995-06-09 | Pasteur Merieux Serums Vacc | Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal. |
| AU693098B2 (en) | 1993-06-09 | 1998-06-25 | Connaught Laboratories Limited | Tandem synthetic HIV-1 peptides |
| FR2763244B1 (fr) * | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
| EP1035137A1 (en) * | 1999-03-12 | 2000-09-13 | Pasteur Merieux Serums Et Vaccins | Method for the reductive amination of polysaccharides |
| CA2366152A1 (en) | 1999-03-19 | 2000-09-28 | Smithkline Beecham Biologicals S.A. | Streptococcus pneumoniae vaccine |
-
2003
- 2003-01-17 FR FR0300488A patent/FR2850106B1/fr not_active Expired - Lifetime
-
2004
- 2004-01-15 US US10/758,142 patent/US7812006B2/en not_active Expired - Lifetime
- 2004-01-16 WO PCT/FR2004/000089 patent/WO2004067574A1/fr not_active Ceased
- 2004-01-16 CA CA2512847A patent/CA2512847C/en not_active Expired - Lifetime
- 2004-01-16 NZ NZ541254A patent/NZ541254A/en not_active IP Right Cessation
- 2004-01-16 AT AT04702733T patent/ATE520718T1/de not_active IP Right Cessation
- 2004-01-16 AU AU2004207647A patent/AU2004207647B2/en not_active Expired
- 2004-01-16 MX MXPA05007533A patent/MXPA05007533A/es active IP Right Grant
- 2004-01-16 KR KR1020057013266A patent/KR101044437B1/ko not_active Expired - Lifetime
- 2004-01-16 EP EP04702733A patent/EP1590373B1/fr not_active Expired - Lifetime
- 2004-01-16 BR BRPI0406819-0A patent/BRPI0406819B1/pt active IP Right Grant
- 2004-01-16 DK DK04702733.9T patent/DK1590373T3/da active
-
2005
- 2005-07-14 IL IL169689A patent/IL169689A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0406819B8 (cg-RX-API-DMAC7.html) | 2021-05-25 |
| IL169689A0 (en) | 2007-07-04 |
| EP1590373A1 (fr) | 2005-11-02 |
| BRPI0406819A (pt) | 2005-12-27 |
| CA2512847C (en) | 2012-08-21 |
| US20040170638A1 (en) | 2004-09-02 |
| EP1590373B1 (fr) | 2011-08-17 |
| DK1590373T3 (da) | 2011-12-05 |
| KR101044437B1 (ko) | 2011-06-27 |
| US7812006B2 (en) | 2010-10-12 |
| BRPI0406819B1 (pt) | 2017-01-03 |
| FR2850106A1 (fr) | 2004-07-23 |
| KR20050093838A (ko) | 2005-09-23 |
| CA2512847A1 (en) | 2004-08-12 |
| WO2004067574A1 (fr) | 2004-08-12 |
| MXPA05007533A (es) | 2005-12-05 |
| AU2004207647B2 (en) | 2010-07-01 |
| ATE520718T1 (de) | 2011-09-15 |
| AU2004207647A1 (en) | 2004-08-12 |
| FR2850106B1 (fr) | 2005-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7494276B2 (ja) | 非天然アミノ酸とのポリペプチド抗原接合体 | |
| CA2512847C (en) | Conjugates obtained by reductive amination of serotype 5 pneumococcus capsular polysaccharide | |
| EP1109576B1 (en) | Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide | |
| JP7132954B2 (ja) | 改善された免疫原性及び結合活性を提供する2価又は多価コンジュゲート多糖を含む多価コンジュゲートワクチン | |
| US20140341909A1 (en) | Conjugation of biomolecules using diels-alder cycloaddition | |
| AU765210B2 (en) | Method for the reductive amination of polysaccharides | |
| HU219672B (hu) | Eljárás egy patogén ágensből nyert antigén poliszacharidból származó oligoszacharid előállítására | |
| CN104815326A (zh) | 一种以异型双功能试剂为连接桥的脑膜炎多糖结合疫苗及其制备方法 | |
| CA3191005A1 (en) | Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f | |
| US5952454A (en) | Linking compounds useful for coupling carbohydrates to amine-containing carriers | |
| US11097000B2 (en) | Klebsiella pneumoniae capsule polysaccharide vaccines | |
| US20170198004A1 (en) | Novel semi-synthetic meningococcal conjugate vaccine | |
| US20020068818A1 (en) | Conjugation of biomolecules using diels-alder cycloaddition | |
| CN121057590A (zh) | 包含缀合荚膜糖抗原的免疫原性组合物及其用途 | |
| CN121729248A (zh) | 疫苗 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| ASS | Change of ownership |
Owner name: SANOFI PASTEUR, FR Free format text: OLD OWNER(S): AVENTIS PASTEUR |
|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 16 JAN 2017 BY CPA GLOBAL Effective date: 20131205 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 JAN 2018 BY CPA GLOBAL Effective date: 20161202 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 JAN 2019 BY CPA GLOBAL Effective date: 20171130 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 JAN 2020 BY CPA GLOBAL Effective date: 20181129 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 JAN 2021 BY CPA GLOBAL Effective date: 20191205 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 JAN 2022 BY CPA GLOBAL Effective date: 20201203 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 JAN 2023 BY CPA GLOBAL Effective date: 20211202 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 JAN 2024 BY CPA GLOBAL Effective date: 20221202 |
|
| EXPY | Patent expired |